anonymous
Guest
anonymous
Guest
Did you stay up the entire night to come up with that epic comeback comment. Talk about pathetic!
Someone has hurt Karen feelingsDid you stay up the entire night to come up with that epic comeback comment. Talk about pathetic!
Someone has hurt Karen feelingsAs usual no clinical discussion or the benefits of the Notso Clear data. How many patients to treat ratio again??
Thank you so much for posting this! I usually peruse Cafepharma for investment ideas and I’m glad I got your input before I invested. This is such a great site to help with investment opportunities.Stock hasn't performed all week. Most investment houses have this rated as a tentative hold or sell position. Get put while you can.
Thank you so much for posting this! I usually peruse Cafepharma for investment ideas and I’m glad I got your input before I invested. This is such a great site to help with investment opportunities.
Yes, why are you a Karen?Glad we were able to save you some money. It's never fun watching your money go up in a bonfire or have executive committee members go to October fest in Germany or spend money on race cars or private spectator boxes at racetracks. Let us know if there is any other information you need.
Interesting comments, are you an employee?Glad we were able to save you some money. It's never fun watching your money go up in a bonfire or have executive committee members go to October fest in Germany or spend money on race cars or private spectator boxes at racetracks. Let us know if there is any other information you need.
Why are you asking, Karen?Interesting comments, are you an employee?
I’m quite interested in getting on board with this latest expansion, does anyone know if the focuses on cardiologists or more on primary care or both? I’d like to stay more focused on specialists, but I’m not ruling out the opportunity. It seems like the company is really focused on relaunching the brand and I’ve heard some good things based on the outcome study for primary prevention.
Has anyone ever engaged in this discussion with you, Karen? STFU! Please explain on this forum why the stock went from $78.00 in 2020 to .74cents presently. Very interested in the opportunity but would like to get a better feel for the job based on your answer.
Has anyone ever engaged in this discussion with you, Karen? STFU
Correct, insults, dumbass.I guess there's no answer to the question. Just insults as usual as this fits right into the culture at Esperion. Good luck as your going to need it.
Correct, insults, dumbass.
What a Karen you areMore insuits from the Ann Arbor crowd. What a bust this drug has been.
More insuits from the Ann Arbor crowd. What a bust this drug has been.